Centralized SmPC with AI-powered Pharmacovigilance Workflows

PubHive tackles pharmacovigilance inefficiencies! Centralized SmPC management and AI workflows boost speed, compliance, and patient safety.

CD BioSciences Unveils Customized C. elegans Maintenance and Storage Services Worldwide

CD BioSciences Demystifies the Process of Antibody Production with its Specialized and Holistic Services

Effective Manipulation of Bacillus subtilis Genome Through Advanced Editing Technologies by Microbiosci

Microbiosci Introduces New Bacillus subtilis 168 Knockout Strains

Creative Biogene Unveils Stable Cell Lines for Use in ADCC and ADCP Cellular Assays

Empower Your Research with Creative Proteomics' Innovative Pull-Down Assay Service

Creative Proteomics Launches Label-free Quantification Service for Advanced Protein Analysis

Creative Proteomics Launches Innovative Ubiquitinated Proteomics Service for Advanced Research

Creative Enzymes Unleashes Revolutionary Trypsin-Chymotrypsin, Elevating Protease Research to New Heights

Huateng Pharma Introduces Versatile Ingredients for Cosmetics and Commodities

Huateng Pharma introduces Tetrahydrocurcumin, a dual-action antioxidant and skin-whitening agent, alongside Pro-xylane and (S)-Pro-xylane, potent anti-ageing agents, and Piroctone Olamine, an effective anti-dandruff solution, emphasizing a commitment to quality and versatility from lab to commercial scale.

Alfa Chemistry Launches Varieties of Biological Reagents for Use in Nucleic Acid Purification Systems

Creative Enzymes Releases Microorganism-Derived Bilirubin Oxidase

CD Formulation Extends Holiday Greetings for 2023 with an Exclusive Discount

Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

BOC Sciences and Spaya Join Forces to Expand Chemical Offerings

BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.

Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome

Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI

Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity

Abzena, a leading CDMO for biologics, collaborates with the FDA on a publication endorsing the MHC Associated Peptide Proteomics (MAPPs) assay for assessing immunogenicity in drug development. The article underscores MAPPs' precision in identifying potential immunogenicity risks in early preclinical stages, reducing the likelihood of anti-drug antibodies (ADAs) and optimizing biologics. Abzena integrates MAPPs into its immunogenicity services, aiming to de-risk drug development. The Chief Scientific Officer, Dr. Campbell Bunce, emphasizes the assay's value in informing drug regions that may induce ADAs. The collaboration aims to expedite safer, more effective therapies for patients.

Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer

Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, today announced that it has entered into a collaboration agreement with MSD, the trade name of Merck & Co Inc., Rahway NJ USA to develop and commercialize AI-powered digital pathology diagnostics for the EU market.